![Apalutamide [Erleada] – (Androgen Receptor Inhibitor)](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E)
Introduction
Apalutamide, sold under the trade name Erleada, is a next-generation androgen receptor inhibitor used to treat advanced prostate cancer. It is particularly effective for non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
Purpose
- Treats non-metastatic castration-resistant prostate cancer (nmCRPC).
- Treats metastatic castration-sensitive prostate cancer (mCSPC) in combination with androgen deprivation therapy (ADT).
- Delays progression to metastatic disease and improves overall survival.
How It Works
Apalutamide binds to androgen receptors on prostate cancer cells, blocking testosterone from stimulating tumor growth. It also prevents androgen receptor activity in the cell nucleus, effectively halting cancer proliferation.
Usage
- Taken as an oral tablet, typically once daily.
- Combined with androgen deprivation therapy (ADT) to suppress testosterone production.
- Regular monitoring of prostate-specific antigen (PSA) levels and imaging studies is recommended to evaluate treatment efficacy.
Considerations
- Common side effects include fatigue, hot flashes, joint pain, and hypertension.
- Rare but serious side effects include seizures and cardiovascular events; patients should be monitored closely for these risks.
- Apalutamide is well-tolerated overall and offers significant benefits for delaying disease progression.
At Crossroads Urology
At Crossroads Urology, Apalutamide is an integral part of advanced prostate cancer care. Our providers tailor treatment plans to optimize outcomes while minimizing side effects, ensuring the best possible quality of life for patients.
Conclusion
Apalutamide [Erleada] is a powerful and effective option for managing advanced prostate cancer, helping patients achieve longer survival and better quality of life. Contact Crossroads Urology today to learn more about this advanced treatment.
